vs
AMICUS THERAPEUTICS, INC.(FOLD)与UNIVERSAL TECHNICAL INSTITUTE INC(UTI)财务数据对比。点击上方公司名可切换其他公司
UNIVERSAL TECHNICAL INSTITUTE INC的季度营收约是AMICUS THERAPEUTICS, INC.的1.2倍($221.4M vs $185.2M),AMICUS THERAPEUTICS, INC.净利率更高(0.9% vs 0.2%,领先0.7%),AMICUS THERAPEUTICS, INC.同比增速更快(23.7% vs 6.7%),过去两年AMICUS THERAPEUTICS, INC.的营收复合增速更高(29.5% vs 11.7%)
Amicus Therapeutics是总部位于美国宾夕法尼亚州费城的生物制药上市企业,2007年在纳斯达克挂牌上市,股票代码为FOLD。上市前,公司曾获得Radius Ventures、迦南合伙人、恩颐投资等多家风险投资机构的资金支持,专注于生物医药领域的研发与商业化布局。
环球技术学院(UTI)是美国的营利性私立技术院校集团,1965年由罗伯特·斯威特创立,专注于提供职业技术类教育课程,培养符合产业需求的技能型人才,在美职业教育领域拥有较长的运营历史与行业经验。
FOLD vs UTI — 直观对比
营收规模更大
UTI
是对方的1.2倍
$185.2M
营收增速更快
FOLD
高出17.0%
6.7%
净利率更高
FOLD
高出0.7%
0.2%
两年增速更快
FOLD
近两年复合增速
11.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $185.2M | $221.4M |
| 净利润 | $1.7M | $433.0K |
| 毛利率 | 85.7% | — |
| 营业利润率 | 8.6% | 0.2% |
| 净利率 | 0.9% | 0.2% |
| 营收同比 | 23.7% | 6.7% |
| 净利润同比 | -88.5% | -60.5% |
| 每股收益(稀释后) | $0.00 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FOLD
UTI
| Q1 26 | — | $221.4M | ||
| Q4 25 | $185.2M | $220.8M | ||
| Q3 25 | $169.1M | $222.4M | ||
| Q2 25 | $154.7M | $204.3M | ||
| Q1 25 | $125.2M | $207.4M | ||
| Q4 24 | $149.7M | $201.4M | ||
| Q3 24 | $141.5M | $196.4M | ||
| Q2 24 | $126.7M | $177.5M |
净利润
FOLD
UTI
| Q1 26 | — | $433.0K | ||
| Q4 25 | $1.7M | $12.8M | ||
| Q3 25 | $17.3M | $18.8M | ||
| Q2 25 | $-24.4M | $10.7M | ||
| Q1 25 | $-21.7M | $11.4M | ||
| Q4 24 | $14.7M | $22.2M | ||
| Q3 24 | $-6.7M | $18.8M | ||
| Q2 24 | $-15.7M | $5.0M |
毛利率
FOLD
UTI
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
营业利润率
FOLD
UTI
| Q1 26 | — | 0.2% | ||
| Q4 25 | 8.6% | 7.1% | ||
| Q3 25 | 20.3% | 11.2% | ||
| Q2 25 | -6.1% | 6.9% | ||
| Q1 25 | -6.3% | 8.1% | ||
| Q4 24 | 10.7% | 13.6% | ||
| Q3 24 | 15.3% | 13.3% | ||
| Q2 24 | 11.8% | 4.2% |
净利率
FOLD
UTI
| Q1 26 | — | 0.2% | ||
| Q4 25 | 0.9% | 5.8% | ||
| Q3 25 | 10.2% | 8.4% | ||
| Q2 25 | -15.8% | 5.2% | ||
| Q1 25 | -17.3% | 5.5% | ||
| Q4 24 | 9.8% | 11.0% | ||
| Q3 24 | -4.8% | 9.6% | ||
| Q2 24 | -12.4% | 2.8% |
每股收益(稀释后)
FOLD
UTI
| Q1 26 | — | $0.01 | ||
| Q4 25 | $0.00 | $0.23 | ||
| Q3 25 | $0.06 | $0.33 | ||
| Q2 25 | $-0.08 | $0.19 | ||
| Q1 25 | $-0.07 | $0.21 | ||
| Q4 24 | $0.05 | $0.40 | ||
| Q3 24 | $-0.02 | $0.35 | ||
| Q2 24 | $-0.05 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $293.5M | $162.0M |
| 总债务越低越好 | $392.7M | $127.8M |
| 股东权益账面价值 | $274.2M | $339.9M |
| 总资产 | $949.9M | $852.2M |
| 负债/权益比越低杠杆越低 | 1.43× | 0.38× |
8季度趋势,按日历期对齐
现金及短期投资
FOLD
UTI
| Q1 26 | — | $162.0M | ||
| Q4 25 | $293.5M | $162.8M | ||
| Q3 25 | $263.8M | $169.1M | ||
| Q2 25 | $231.0M | $70.7M | ||
| Q1 25 | $250.6M | $96.0M | ||
| Q4 24 | $249.9M | $172.0M | ||
| Q3 24 | $249.8M | $161.9M | ||
| Q2 24 | $260.1M | $115.5M |
总债务
FOLD
UTI
| Q1 26 | — | $127.8M | ||
| Q4 25 | $392.7M | $101.4M | ||
| Q3 25 | $392.0M | $87.1M | ||
| Q2 25 | $391.3M | $73.8M | ||
| Q1 25 | $390.7M | $94.4M | ||
| Q4 24 | $390.1M | $120.1M | ||
| Q3 24 | $389.5M | $125.7M | ||
| Q2 24 | $388.9M | $137.3M |
股东权益
FOLD
UTI
| Q1 26 | — | $339.9M | ||
| Q4 25 | $274.2M | $335.9M | ||
| Q3 25 | $230.4M | $328.1M | ||
| Q2 25 | $204.3M | $306.8M | ||
| Q1 25 | $193.6M | $293.9M | ||
| Q4 24 | $194.0M | $280.0M | ||
| Q3 24 | $178.8M | $260.2M | ||
| Q2 24 | $132.5M | $239.4M |
总资产
FOLD
UTI
| Q1 26 | — | $852.2M | ||
| Q4 25 | $949.9M | $834.0M | ||
| Q3 25 | $868.8M | $826.1M | ||
| Q2 25 | $815.3M | $740.8M | ||
| Q1 25 | $789.8M | $720.4M | ||
| Q4 24 | $785.0M | $753.8M | ||
| Q3 24 | $786.6M | $744.6M | ||
| Q2 24 | $749.5M | $706.0M |
负债/权益比
FOLD
UTI
| Q1 26 | — | 0.38× | ||
| Q4 25 | 1.43× | 0.30× | ||
| Q3 25 | 1.70× | 0.27× | ||
| Q2 25 | 1.92× | 0.24× | ||
| Q1 25 | 2.02× | 0.32× | ||
| Q4 24 | 2.01× | 0.43× | ||
| Q3 24 | 2.18× | 0.48× | ||
| Q2 24 | 2.93× | 0.57× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $16.3M | $7.1M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | — |
| 自由现金流率自由现金流/营收 | 8.6% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | 9.62× | 16.33× |
| 过去12个月自由现金流最近4个季度 | $29.8M | — |
8季度趋势,按日历期对齐
经营现金流
FOLD
UTI
| Q1 26 | — | $7.1M | ||
| Q4 25 | $16.3M | $3.1M | ||
| Q3 25 | $35.7M | $57.1M | ||
| Q2 25 | $-26.5M | $18.1M | ||
| Q1 25 | $7.8M | $-789.0K | ||
| Q4 24 | $-3.9M | $23.0M | ||
| Q3 24 | $-23.0M | $67.5M | ||
| Q2 24 | $22.7M | $10.0M |
自由现金流
FOLD
UTI
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $-19.2M | ||
| Q3 25 | $35.3M | $40.6M | ||
| Q2 25 | $-28.9M | $6.8M | ||
| Q1 25 | $7.5M | $-11.7M | ||
| Q4 24 | $-4.2M | $19.6M | ||
| Q3 24 | $-23.3M | $60.0M | ||
| Q2 24 | $21.6M | $3.0M |
自由现金流率
FOLD
UTI
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | -8.7% | ||
| Q3 25 | 20.9% | 18.3% | ||
| Q2 25 | -18.7% | 3.4% | ||
| Q1 25 | 6.0% | -5.7% | ||
| Q4 24 | -2.8% | 9.7% | ||
| Q3 24 | -16.5% | 30.6% | ||
| Q2 24 | 17.0% | 1.7% |
资本支出强度
FOLD
UTI
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 10.1% | ||
| Q3 25 | 0.2% | 7.4% | ||
| Q2 25 | 1.6% | 5.5% | ||
| Q1 25 | 0.2% | 5.3% | ||
| Q4 24 | 0.2% | 1.7% | ||
| Q3 24 | 0.3% | 3.8% | ||
| Q2 24 | 0.9% | 4.0% |
现金转化率
FOLD
UTI
| Q1 26 | — | 16.33× | ||
| Q4 25 | 9.62× | 0.24× | ||
| Q3 25 | 2.06× | 3.04× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | -0.07× | ||
| Q4 24 | -0.27× | 1.04× | ||
| Q3 24 | — | 3.58× | ||
| Q2 24 | — | 2.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
UTI
暂无分部数据